Benitec Biopharma Inc. — Form 8-K
Filed September 30, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 12/100
What the filing says
On September 29, 2026, Benitec Biopharma reported a change in its registered accounting firm under Item 4.01. No specific counterparties, dollar amounts, or reasons for the change are detailed in the filing header or document listing provided. The actual 8-K content describing the accountant transition is not included in this submission text.
Why this rating
Routine auditor rotation. No financial, operational, or strategic impact disclosed; standard corporate governance event.
Extracted items
See more from September 30, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.